NuCana (NCNA) Shares Outstanding (2017 - 2025)
NuCana's (NCNA) quarterly Shares Outstanding came in at $27.7 billion in Q4 2025, up 15083.66% year-on-year from N/an in Q4 2024, and up 15083.66% quarter-over-quarter from $182.3 million in Q4 2024.
NuCana (NCNA) Shares Outstanding (2017 - 2025) Analysis & Trends
NuCana has disclosed Shares Outstanding across 9 years of filings, most recently posting $27.7 billion for Q4 2025.
- Shares Outstanding for Q4 2025 came in at $27.7 billion, up 15083.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $27.7 billion (up 15083.66% YoY), and the FY2025 annual result was $27.4 billion, up 15012.14% from the prior year.
- Shares Outstanding came in at $27.7 billion for Q4 2025 at NuCana, up from $182.3 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $27.7 billion in Q4 2025 to a low of $61.4 million in Q4 2022.
- The 5-year median for Shares Outstanding is $70.3 million (2021), against an average of $5.6 billion.
- Across the five-year window, Shares Outstanding decreased 12.67% in 2022 and surged 15083.66% in 2025, its largest moves.
- NuCana's Shares Outstanding stood at $70.3 million in 2021, then decreased by 12.67% to $61.4 million in 2022, then gained by 6.8% to $65.6 million in 2023, then soared by 177.87% to $182.3 million in 2024, then soared by 15083.66% to $27.7 billion in 2025.
- The last three Shares Outstanding figures came in at $27.7 billion (Q4 2025), $182.3 million (Q4 2024), and $65.6 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 27.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2025 | 27.68 Bn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2024 | 182.31 Mn |
| Dec 31, 2023 | 65.61 Mn |
| Dec 31, 2023 | 65.61 Mn |
| Dec 31, 2023 | 65.61 Mn |
| Dec 31, 2023 | 65.61 Mn |